Skip to content

Homeopathic treatment of muscle pain

Efficacy of individualized homoeopathic medicines in the treatment of fibromyalgia in adults: A double-blind, randomized, placebo-controlled trial - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077618
Enrollment
54
Registered
2024-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M797- Fibromyalgia

Interventions

Intervention1: Individualized homoeopathic medicines in individualized dosage in centesimal potencies plus concomitant care: The proposed intervention entails the administration of prescribed homoeop
the dosage and repetition depend on the specific needs of each patient management guidelines will be given as in the experimental arm.The therapy lasted for three months. The medications and placebos

Sponsors

D.N.De Homoeopathic Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who have received a diagnosis of primary fibromyalgia according to The American College of Rheumatology 2010 criteria for the classification of fibromyalgia ? Widespread pain score 7 or more ? Based on severity of symptom (SS 5 or more) 2. Age between 18 and 65 years 3. Symptoms are present for at least 3 months. 4. Participants of either sex or transgender. 5. Patients ability to understand English / Hindi / Bengali

Exclusion criteria

Exclusion criteria: 1.Not providing with written informed consent of participation. 2. Participants despite meeting the ACR 2010 fibromyalgia criteria , having PDS / FM Scale (WPI+SS), None (0-3) , Mild (4–7) , Moderate (8-11), Very severe (20–31) 3. A current diagnosis of infection or Musculoskeletal inflammatory conditions 4. Non-ambulant patients. 5. Self-reported conditions other than fibromyalgia. 6. Patients who are too sick for consultation. 7. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled systemic or life-threatening illness affecting quality of life or any organ failure. 8. Pregnancy, puerperal women and lactating mother. 9. Tobacco chewing and/or smoking, alcoholism and/or any form(s) of substance abuse and/or dependence (TAPS tool) 10. Self-reported immune-compromised state, AIDS, hepatitis 11. Undergoing homoeopathic treatment for any chronic disease within last 3 months. 12. Simultaneous participation in any other clinical trial

Design outcomes

Primary

MeasureTime frame
The Revised Fibromyalgia Impact Questionnaire (FIQR)Timepoint: Baseline, and every month, up to 3 months

Secondary

MeasureTime frame
Multi Dimensional questionnaire for patient reported outcome measures - Fibromyalgia (PROM FM)Timepoint: Baseline, and every month, up to 3 months;Measure yourself Medical Outcome Profile v-2 (MYMOP-2) questionnaireTimepoint: Baseline, and every month, up to 3 months

Countries

India

Contacts

Public ContactVeena Prakash Bharti

D.N.De Homoeopathic Medical College

drvpbharti@gmail.com9231692840

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026